The advent of biosimilars has significantly altered the dynamics of the generic drug industry in Europe. Biosimilars are biological products […]

The pharmaceutical industry is a complex and competitive landscape, especially after the approval of an Abbreviated New Drug Application (ANDA).

The global generic drug market is expected to grow from $435.3 billion in 2023 to $655.8 billion by 2028, at

The pharmaceutical industry is undergoing a significant shift towards digital transformation, and generic drug development is no exception. This transformation

Generic drug development is a cornerstone of modern healthcare, offering affordable alternatives to brand-name medications while maintaining the same quality,

The generic drug market is a highly competitive and dynamic industry, with both opportunities and challenges. To succeed, generic drug

When selecting a contract development and manufacturing organization (CDMO) to partner with, pharmaceutical and biotechnology companies must consider several key

Partnering with Contract Development and Manufacturing Organizations (CDMOs) has become a strategic imperative for pharmaceutical and biotech companies seeking to

Navigating the world of biosimilars is no small feat. For business professionals in the biopharmaceutical industry, interacting with regulatory agencies